Correlation Between Emmaus Life and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Emmaus Life and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emmaus Life and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emmaus Life Sciences and NRx Pharmaceuticals, you can compare the effects of market volatilities on Emmaus Life and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emmaus Life with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emmaus Life and NRx Pharmaceuticals.
Diversification Opportunities for Emmaus Life and NRx Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Emmaus and NRx is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Emmaus Life Sciences and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Emmaus Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emmaus Life Sciences are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Emmaus Life i.e., Emmaus Life and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Emmaus Life and NRx Pharmaceuticals
If you would invest 5.00 in NRx Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of 1.70 from holding NRx Pharmaceuticals or generate 34.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Emmaus Life Sciences vs. NRx Pharmaceuticals
Performance |
Timeline |
Emmaus Life Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NRx Pharmaceuticals |
Emmaus Life and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emmaus Life and NRx Pharmaceuticals
The main advantage of trading using opposite Emmaus Life and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emmaus Life position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.Emmaus Life vs. NRx Pharmaceuticals | Emmaus Life vs. Cell Source | Emmaus Life vs. Anebulo Pharmaceuticals | Emmaus Life vs. Adagene |
NRx Pharmaceuticals vs. Fate Therapeutics | NRx Pharmaceuticals vs. Sana Biotechnology | NRx Pharmaceuticals vs. Caribou Biosciences | NRx Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |